Carvedilol Protects against Doxorubicin-Induced Mitochondrial Cardiomyopathy
Several cytopathic mechanisms have been suggested to mediate the dose-limiting cumulative and irreversible cardiomyopathy caused by doxorubicin. Recent evidence indicates that oxidative stress and mitochondrial dysfunction are key factors in the pathogenic process. The objective of this investigatio...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2002
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10316/5412 |
| País: | Portugal |
| Oai: | oai:estudogeral.sib.uc.pt:10316/5412 |